Haematologica (Nov 2008)

Anthropometric characteristics and non-Hodgkin’s lymphoma and multiple myeloma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)

  • Julie A. Britton,
  • Aneire E. Khan,
  • Sabine Rohrmann,
  • Nikolaus Becker,
  • Jakob Linseisen,
  • Alexandra Nieters,
  • Rudolf Kaaks,
  • Anne Tjønneland,
  • Jytte Halkjær,
  • Marianne Tang Severinsen,
  • Kim Overvad,
  • Tobias Pischon,
  • Heiner Boeing,
  • Antonia Trichopoulou,
  • Victoria Kalapothaki,
  • Dimitrios Trichopoulos,
  • Amalia Mattiello,
  • Giovanna Tagliabue,
  • Carlotta Sacerdote,
  • Petra H.M. Peeters,
  • H. Bas Bueno-de-Mesquita,
  • Eva Ardanaz,
  • Carmen Navarro,
  • Paula Jakszyn,
  • Jone M. Altzibar,
  • Göran Hallmans,
  • Beatrice Malmer,
  • Göran Berglund,
  • Jonas Manjer,
  • Naomi Allen,
  • Timothy Key,
  • Sheila Bingham,
  • Hervé Besson,
  • Pietro Ferrari,
  • Mazda Jenab,
  • Paolo Boffetta,
  • Paolo Vineis,
  • Elio Riboli

DOI
https://doi.org/10.3324/haematol.13078
Journal volume & issue
Vol. 93, no. 11

Abstract

Read online

Background The incidences of non-Hodgkin’s lymphoma and multiple myeloma are increasing steadily. It has been hypothesized that this may be due, in part, to the parallel rising prevalence of obesity. It is biologically plausible that anthropometric characteristics can infuence the risk of non-Hodgkin’s lymphoma and multiple myeloma.Design and Methods In the context of the European Prospective Investigation into Cancer and Nutrition (EPIC), anthropometric characteristics were assessed in 371,983 cancer-free individuals at baseline. During the 8.5 years of follow-up, 1,219 histologically confirmed incident cases of non-Hodgkin’s lymphoma and multiple myeloma occurred in 609 men and 610 women. Gender-specific proportional hazards models were used to estimate relative risks and 95% confidence intervals (95% CI) of development of non-Hodgkin’s lymphoma and multiple myeloma in relation to the anthropometric characteristics.Results Height was associated with overall non-Hodgkin’s lymphoma and multiple myeloma in women (RR 1.50, 95% CI 1.14–1.98) for highest versus lowest quartile; p-trend < 0.01) but not in men. Neither obesity (weight and body mass index) nor abdominal fat (waist-to-hip ratio, waist or hip circumference) measures were positively associated with overall non-Hodgkin’s lymphoma and multiple myeloma. Relative risks for highest versus lowest body mass index quartile were 1.09 (95% CI 0.85–1.38) and 0.92 (95% CI 0.71–1.19) for men and women, respectively. Women in the upper body mass index quartile were at greater risk of diffuse large B-cell lymphoma (RR 2.18, 95% CI 1.05–4.53) and taller women had an elevated risk of follicular lymphoma (RR 1.25, 95% CI 0.59–2.62). Among men, height and body mass index were non-significantly, positively related to follicular lymphoma. Multiple myeloma risk alone was elevated for taller women (RR 2.34, 95% CI 1.29–4.21) and heavier men (RR 1.77, 95% CI 1.02–3.05).Conclusions The EPIC analyses support an association between height and overall non-Hodgkin’s lymphoma and multiple myeloma among women and suggest heterogeneous subtype associations. This is one of the first prospective studies focusing on central adiposity and non-Hodgkin’s lymphoma subtypes.